Zhong, Ling
Krummenacher, Claude
Zhang, Wanlin
Hong, Junping
Feng, Qisheng
Zhao, Qinjian
Chen, Yixin
Zeng, Mu-Sheng
Zeng, Yi-Xin
Xu, Miao
Zhang, Xiao
Funding for this research was provided by:
National Natural Science Foundation of China (81872228)
Article History
Received: 26 July 2022
Accepted: 30 October 2022
First Online: 23 November 2022
Declarations
:
: Sera were collected from age 40 to 60 EBV positive healthy carriers and the gender was documented by the investigators. This study was approved by the Institutional Ethics Committee of the Sun Yat-sen University Cancer Center, Guangdong, China. Written informed consent was obtained from all participants. The animal experiments were approved by the Sun Yat-sen University Cancer Center Care and Use committee.
: Not applicable.
: The authors declare no competing interests.